Top Insider Tidings
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Top Insider Tidings
No Result
View All Result
Home Editor's Pick

GOP senator’s ‘Federal Fumbles’ report highlights $240M spent on transgender rat testing

by
February 2, 2026
in Editor's Pick
0
GOP senator’s ‘Federal Fumbles’ report highlights $240M spent on transgender rat testing

A new report from a Senate Republican showed that in the last year, the federal government wasted millions on transgender animal tests, lab testing beagles in China and aborted fetal tissue research. 

In his 9th annual edition of ‘Federal Fumbles,’ Sen. James Lankford, R-Okla., found several instances of waste, fraud and abuse in the federal government, and he laid out a game plan to address some of the shortcomings of the past year. 

Lankford noted that after the first year of President Donald Trump’s second term, the Republican-controlled Congress was able to improve efficiency, save billions in taxpayer dollars and redefine spending in Washington, D.C. 

‘However, the work is far from over,’ Lankford wrote in the report.

‘Too often, the federal government is gridlocked, unresponsive and inefficient,’ he continued. ‘We must continue pushing through bureaucratic red tape to make the government work better for you, the taxpayer. We have so much still to do.’

Some of the more egregious examples of federal waste laid out in the report included a handful of grant programs from the National Institute of Health (NIH) held over from the Biden administration.

Among those were a roughly $240 million study on transgender ‘animal experiments involving mice, rats and monkeys.’ That grant program was eventually terminated by Trump’s Department of Government Efficiency (DOGE).

‘These NIH-funded studies attempted to model transgender adults and children by subjecting animals to hormone regimens and surgical procedures,’ Lankford wrote. 

In 2024, the Biden-led NIH funded $53 million worth of grants that allowed for ‘research using human fetal tissue obtained from elective abortions.’ And last year it was found that 17 of those grants were still active. 

Lankford noted that the NIH canceled the grants when the money flow became public after watchdog the White Coat Waste Project found that the agency was still funding them, and that the Trump administration went a step further to cancel all research involving aborted fetal tissue. 

Still, Lankford argued that unless Congress passed a law regarding the issue, ‘another pro-abortion Administration could resume or expand such projects at any time, forcing taxpayers to fund research that is both immoral and scientifically obsolete.’

Though the sums were not as eye-popping, Lankford also found that $124,000 in taxpayer money was sent to China to conduct drug research and experiments on ‘up to 300 beagles per week.’ 

Lankford said NIH announced it would not renew the contract after national scrutiny, but that there are still ’18 Chinese animal research laboratories, including several with troubling ties to the Chinese Communist Party and the People’s Liberation Army, [that] still hold NIH approval to receive U.S. funding.’

This post appeared first on FOX NEWS
Previous Post

House panel moves to consider criminal referrals for the Clintons

Next Post

Sanctioned Russian jet touches down in Cuba, echoing secret flights before Maduro’s ouster

Next Post
Nicki Minaj backs voter ID laws in X post

Nicki Minaj backs voter ID laws in X post

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Here’s how the DHS shutdown could impact the lives of everyday Americans

    Here’s how the DHS shutdown could impact the lives of everyday Americans

    February 14, 2026
    ‘Fiction’: House Republican campaign chair dismisses Democrats’ expanding GOP target map

    ‘Fiction’: House Republican campaign chair dismisses Democrats’ expanding GOP target map

    February 14, 2026
    Rosie O’Donnell quietly returns to US after abandoning country over Trump’s victory

    Rosie O’Donnell quietly returns to US after abandoning country over Trump’s victory

    February 14, 2026
    Rubio steps into Munich spotlight as Trump leans on him to carry Vance’s populist message abroad

    Rubio steps into Munich spotlight as Trump leans on him to carry Vance’s populist message abroad

    February 14, 2026
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TopInsiderTidings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 topinsidertidings.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Editor’s Pick

    Disclaimer: TopInsiderTidings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.